Nexell Planning To Seek Labeling Expansion For Isolex 300i In 2001

Nexell Therapeutics plans to file two premarket approval applications in the second half of 2001 to expand labeling for its Isolex 300i magnetic cell selection system, which gained FDA approval July 6.